HD Research HD Research Webinar Series

HD Research Webinars Series


In an effort to increase research communication between HD families/patients and the HD Scientists around the world, HDSA offers the HD Research Webinar Series, a series of monthly webinars on current research topics presented by HD experts from around the globe. The webinars commence at 12:00 PM EST and run for approximately 30-40 minutes, with 20-30 minutes available for a question and answer session through a chat feature of the webinar software. Each session will end by 1:00 PM EST. We chose this time to allow you to participate in this over your lunch hour, making this a virtual luncheon seminar.

Upcoming Webinars

TITLE: Interim Results from the Vaccinex SIGNAL Trial
PRESENTED BY: Maurice Zauderer
DATE: 9/19/17
TIME: 12PM (EDT)
REGISTER: Click: https://attendee.gotowebinar.com/register/6535926309001073665

Webinars

If your have questions or suggestions for future seminar topics, please send them to researchupdates@hdsa.org

Webinars

TITLE PRESENTERS ORIGINAL AIR DATE
Potential new drug target identified that could correct protein misfolding in Huntington’s disease Dennis J. Thiele & Rocio Gomez-Pastor, Ph.D Wed, Apr 5, 2017
2016 Year in Review 2/1/17
PRIDE-HD Clinical Trial Results Dr. Andrew McGarry Wednesday, January 11th, 2017
Is HD More Prevalent Than Previously Thought? Chris Kay 9/7/16
The FDA and Patient Engagement – What’s Next for the HD Community Dr. John Whyte 5/12/2016
PPAR delta is decreased in HD and can be targeted therapeutically Al LaSpada, MD, PhD 4/28/2016
LEGATO-HD: A Clinical Study in Subjects with Huntington's Disease to Assess the Efficacy and Safety of Laquinimod Spyros Papapetropoulos, MD, PhD 2/3/16
The role of complement and synaptic loss in driving disease progression in Huntington’s disease Daniel Wilton, PhD 3/16/16
2015: The Year in Review for HD Research George Yohrling, PhD 1/21/16
At Home Monitoring of Sleep/Wake Cycles in Huntington’s Disease Patients Dr. Dawn Loh December 9, 2015
PF-02545920: An Investigational Pfizer Compound for the Treatment of Huntington's Disease Ottavio Vitolo November 19, 2015
Genetic variation in huntingtin promoter as a bidirectional genetic modifier of Huntington’s disease Dr. Kristina Becanovic October 7, 2015
The spread of mutant huntingtin protein from cell to cell and its implications for transplant therapies for Huntington's disease Francesca Cicchetti, PhD April 16, 2015
Suppression of somatic expansion of CAG tract delays onset of disease in mouse model of HD Helen Budworth, PhD September 16, 2015
Histone deacetylase (HDAC) inhibitors: assessing their potential for clinical use. Beth Thomas, PhD March 19, 2015
Stem Cells in HD Research and Therapeutics Jamshid Arjomand, PhD February 27, 2013
Huntingtin ASOs Holly Kordasiewicz, PhD March 19, 2013
Sleep/Circadian Dysfunction in HD Jenny Morton, PhD- University of Cambridge April 24, 2013
Enroll-HD Joe Giuliano, CHDI Foundation May 22, 2013
Kids-HD: Brain Imaging Research Study Peg Nopoulos July 24, 2013
Clinical Trials in Premanifest HD: Review of PREQUEL Results and Prospects for the Future Chris Ross August 22, 2013
PDE10 Imaging in HD Patients Ken Marek September 26, 2013
“FIRST-HD: A clinical Trial to test effectiveness of novel drug for reducing HD chorea” Sam Frank, MD and Claudia Testa, MD, PhD November 21, 2013
Year in Review George Yohrling, Ph.D. January, 22, 2014
Silencing Mutant Huntingtin as a Therapy for HD Neil Aronin, MD (University of Massachusetts Medical School) March 27, 2014
Mind the Gap: Thinking Big to Bridge Drug Development in Huntington’s Disease David Howland, Ph.D. May 22, 2014
Using mouse models to gain therapeutic insights for Huntington's disease William Yang, MD, PhD (UCLA) August 21, 201
Allele-specific silencing of mutant huntingtin gene with ASOs Dr. Amber Southwell (University of British Columbia) September 24, 2014
Stem Cell Approaches for HD Dr. Vicki Wheelock and Dr. Jan Nolta (UC-Davis) October 7, 2014
2014: The Year in Review for HD Research George Yohrling, PhD January 21, 2015
Pride- HD: a dose finding, safety and efficacy study of pridopidine in HD patients Dr. Michael Hayden February 10, 2015
The spread of mutant huntingtin protein from cell to cell and its implications for transplant therapies for Huntington's disease Francesca Cicchetti, PhD April 16, 2015
CLICK HERE TO VIEW THE HDSA CAREGIVER’S CORNER WEBINAR SERIES
Share Tweet

Share a link